当前位置：首页 > 文献互助 > 互助详情

期刊论文Additive Manufacturing for Extracellular Vesicle Therapeutics: Engineering Strategies for Production, Isolation, and Delivery复制

用户1oor83NH7Asw 1个月前 66 已完结

1. 系统已在2026-07-25 07:44:38对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1002/adhm.71439复制

文献链接: https://advanced.onlinelibrary.wiley.com/doi/10.1002/adhm.71439复制

其他信息:

出版社: Wiley
作者: Renz Gabriel Garduque; Sanjairaj Vijayavenkataraman
全文下载地址: https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.71439

上一篇：Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

下一篇：Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

互助时间线

2026-07-23 07:43:29 [完结求助]

系统完结了求助, 已自动确认了HappyUser1应助的文件是正确的, 求助状态变成已完结

2026-07-18 07:44:38 [上传文件]

HappyUser1上传了文件(pdf 2.18 MB), 求助状态变成待确认

2026-07-18 07:43:29 [发起求助]

最新发布的求助

The Long Revolution (Part I) 4分钟前

Advances and prospects of multifunctional biochar-based materials from organic solid waste of traditional Chinese medicine: A review 21分钟前

Biowastes and derived green sorbents for water decontamination: Insights on thermochemical conversion strategies 54分钟前

Does Trading by ETF and Mutual Fund Investors Hurt Performance? Evidence from Time- and Dollar-Weighted Returns 1小时前

Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial 2小时前

Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY 3小时前

Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial 3小时前

https://doi.org/10.1063/1.3499306 3小时前

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial 3小时前

On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial 3小时前

Redox‐Neutral Vicinal Dialkylation of Aryl Boronic Esters via the Palladium/Norbornene Cooperative Catalysis 3小时前

CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer 3小时前